| Unknown | Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Particip Alopecia Areata | Phase 2 | 2023-04-14 |
| Unknown | Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With D Atopic Dermatitis | Phase 2 | 2022-12-21 |
| Completed | Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2022-03-16 |
| Completed | A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tol Atopic Dermatitis | Phase 1 | 2019-09-09 |
| Completed | Study of ASLAN004 in Healthy Subjects Allergic Disorder | Phase 1 | 2018-10-15 |
| Withdrawn | Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer Advanced or Metastatic Biliary Tract Cancer | Phase 2 | 2018-05-01 |
| Completed | A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 2 | 2018-01-05 |
| Completed | Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer Biliary Tract Cancer | Phase 2 | 2017-12-19 |
| Completed | Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varl Healthy Volunteers | Phase 1 | 2017-11-23 |
| Completed | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) Gastric Cancer | Phase 2 / Phase 3 | 2017-08-31 |
| Completed | Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer Biliary Tract Cancer | Phase 2 / Phase 3 | 2017-07-04 |
| Completed | A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours Advanced or Metastatic Biliary Tract Cancer, Advanced or Metastatic Solid Tumors | Phase 1 | 2017-01-31 |
| Terminated | Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC Biliary Tract Cancer | Phase 1 / Phase 2 | 2016-12-13 |
| Completed | ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Syste Cholangiocarcinoma | Phase 2 | 2015-11-16 |
| Completed | Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab Metastatic Breast Cancer | Phase 2 | 2014-12-29 |
| Completed | A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN00 Healthy Elderly Subjects (Age ≥55 Years) | Phase 1 | 2014-10-01 |
| Completed | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine Solid Tumor | Phase 1 | 2014-08-05 |
| Completed | Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003 Healthy Volunteers | Phase 1 | 2013-08-01 |
| Completed | A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours Malignant Solid Tumour | Phase 1 | 2012-10-01 |
| Completed | A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Stomach Neoplasms, Cancer of Stomach, Cancer of the Stomach | Phase 2 | 2012-03-01 |